section 1. Introduction -- section 2. Biomarker development and qualification in the pharmaceutical industry -- section 3. Toxicogenomic biomarkers -- section 4. Biomarkers of drug safety -- section 5. Consortia -- section 6. Path to regulatory qualification process development.
Reproduction
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.